Stoke Therapeutics, Inc.

Swiss National Bank STOK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

75,700

Value ($000)

2,403

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,403	0.0%	75,700	12/31/2025
2025 Q3	11/13/2025	1,741	0.0%	74,100	9/30/2025
2025 Q2	8/12/2025	704	0.0%	62,000	6/30/2025
2025 Q1	5/12/2025	448	0.0%	67,300	3/31/2025
2024 Q4	2/10/2025	742	0.0%	67,300	12/31/2024
2024 Q3	11/7/2024	687	0.0%	55,900	9/30/2024
2024 Q2	8/8/2024	897	0.0%	66,400	6/30/2024
2023 Q3	11/8/2023	171	0.0%	43,300	9/30/2023
2023 Q2	8/9/2023	460	0.0%	43,300	6/30/2023
2023 Q1	5/10/2023	284	0.0%	34,100	3/31/2023
2022 Q4	2/8/2023	343	0.0%	37,200	12/31/2022
2022 Q3	11/9/2022	478	0.0%	37,200	9/30/2022
2022 Q2	8/9/2022	460	0.0%	34,800	6/30/2022
2022 Q1	5/9/2022	642	0.0%	30,500	3/31/2022
2021 Q4	2/8/2022	677	0.0%	28,200	12/31/2021
2021 Q3	11/8/2021	717	0.0%	28,200	9/30/2021
2021 Q2	8/6/2021	949	0.0%	28,200	6/30/2021
2021 Q1	5/7/2021	800	0.0%	20,600	3/31/2021
2020 Q4	2/5/2021	1,164	0.0%	18,800	12/31/2020
2020 Q3	11/9/2020	733	0.0%	21,900	9/30/2020
2020 Q2	8/5/2020	522	0.0%	21,900	6/30/2020
2020 Q1	5/8/2020	357	0.0%	15,600	3/31/2020
2019 Q4	2/6/2020	442	0.0%	15,600	12/31/2019